Actively Recruiting
Cutaneous Squamous Cell Carcinoma Staging Study
Led by Queen Mary University of London · Updated on 2026-04-02
1500
Participants Needed
2
Research Sites
266 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Cutaneous squamous cell carcinoma (CSCC) is the second most common form of skin cancer, and one of the most common cancers worldwide. The majority of CSCCs are easily removed by surgery and have excellent prognosis. However, a small subset has poor outcomes, including secondary spread in the body (metastasis) and death. The investigators will look at existing CSCC in people from two UK dermatology centres. The investigators will then evaluate the accuracy of current staging systems in predicting risk of poor outcomes in people. The investigators hope that this project will improve the management of patients with CSCC by validating the predictive power of currently available histological staging classifications for cSCC. In the second stage of the study, The investigators will see whether better prediction tools can be found.
CONDITIONS
Official Title
Cutaneous Squamous Cell Carcinoma Staging Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Over 18 years old with diagnosis of CSCC
You will not qualify if you...
- Patients who decline for their data to be used for research purposes
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Whipps Cross University Hospital
London, United Kingdom, E11 1NR
Actively Recruiting
2
Dr Emilia Peleva
London, United Kingdom
Active, Not Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here